Clinical Trial Update: A Study to Evaluate the Efficacy,Safety,Tolerability,Pharmacokinetics,and Immunogenicty of Plonmarlimab in Subjects With Acute Gouty Arthritis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating Plonmarlimab for acute gouty arthritis, assessing efficacy, safety, tolerability, pharmacokinetics, and immunogenicity; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gouty Arthritis

Drugs mentioned

• Plonmarlimab (Plonmarlimab)

Snippet

Sponsor: TJ Biopharma Co., Ltd. | Conditions: Acute Gouty Arthritis | Phase 2 | Status: RECRUITING